Call for Abstract

2nd International Conference on Hypertension & Healthcare, will be organized around the theme “New insights in diagnosis and management for hypertension”

Hypertension 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Hypertension 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Hypertension, additionally called high vital sign or blood vessel cardiovascular disease could be a chronic medical condition during which the blood pressure within the arteries is elevated. This session principally covers the various sorts of cardiovascular disease and their assessment. There are 2 primary cardiovascular disease sorts. For ninety fifth of individuals with high blood pressure, the reason behind their cardiovascular disease is unknown — this can be referred to as essential, or primary, cardiovascular disease. Once a cause may be found, the condition is termed secondary. Isolated systolic hypertension, high blood pressure, and resistant hypertension are all recognized hypertension sorts with specific diagnostic criteria.
Assessment of cardiovascular disease primarily includes: Confirmation of hypertension, Risk factors, Underlying causes, organ injury & Indications and contraindications for medication medicine.
Hypertension could be a major risk issue for cardiopathy and stroke. Globally, the general prevalence of raised vital sign in adults aged twenty five and over was around four-hundredth in 2008. As a result of increase and ageing, the amount of individuals with uncontrolled cardiovascular disease rose from 600 million in 1980 to just about 1 billion in 2008. The national Million Hearts initiative endeavours to extend the amount of persons whose cardiovascular disease is in check, by ten million, as a part of its goal to forestall one million heart attacks and strokes by the year 2017.

Related Conferences:

  1. 6th Clinical Cardiology Conference, November 30-December 02, 2015 San Antonio, USA
  2. Euro Cardiology Conference, October 24-26, 2016 Valencia, Spain
  3. 8th Clinical Cardiology Conference, November 14-16, 2016 San Francisco, California
  4. 17th  Cardiologists Meeting  June 19-21, 2017 Paris
  5. 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy
  6. The Pacific Northwest Cardiovascular Summit 2015, Portland, Oregon
  7. Hypertension 2015, Washington, DC, USA
  8. 3rd Annual International Conference on Cardiology & Cardiovascular Medicine Research, Singapore, Singapore
  9. 3rd International 4 Corners of Cardiology Meeting, Melbourne, Australia
  • Track 1-1Primary hypertension
  • Track 1-2Secondary hypertension
  • Track 1-3Isolated systolic hypertension
  • Track 1-4Malignant hypertension
  • Track 1-5Resistant hypertension
  • Track 1-6Indications and contraindications for antihypertensive drugs

Hypertension (high blood pressure) refers to the pressure that blood applies to the inner walls of the arteries. Obesity will increase the chance of the event of cardiovascular disease. The individual session in the main focuses on obesity-related cardiovascular disease, its interaction with the outcomes of hypertension, risk factors, treatment and management of fleshiness induced cardiovascular disease. Obesity-associated arterial hypertension is characterised by activation of the sympathetic system, activation of the renin-angiotensin system, and sodium retention, among different abnormalities. It's calculable that excess weight, accounted for about twenty sixth of cases of cardiovascular disease in men and twenty eighth in ladies, and for about twenty third of cases of coronary cardiovascular disease in men and 15 % in ladies. Obese people have a rise in adipose tissue that will increase their tube resistance and successively will increase the work the heart must do to pump blood throughout the body. Indicators for risk of cardiovascular disease embody fleshiness, abdominal fleshiness and weight gain.

Anti-hypertension medications ought to be started if hypertension is diagnosed. But, with weight-loss, a major fall in force per unit area could allow a decrease within the range of medicines taken or decrease the quantity of medication taken. Prevention would be better than any drug.

Given the vital pathophysiologic links between weight and cardiovascular disease represented, a major increase within the prevalence of cardiovascular disease in returning years can be expected, if trends of increasing weight within the population don't seem to be stabilised and reversed.

Related Conferences:

  1. 4th Obesity & Weight Management Conference, December 07-09, 2015 Atlanta, USA
  2. 5th Obesity & Weight Management Conference, December 05-07, 2016 Philadelphia, USA
  3. 3rd Health Informatics Conference, June 27-29, 2016 New Orleans, USA
  4. 6th Global Healthcare Conference, August 22-24, 2016 Philadelphia, USA
  5. Healthcare Conference, November 9-11, 2015 Dubai, UAE
  6. 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension 2015, Istanbul, Turkey
  7. British Hypertension Society Annual Scientific Meeting 2015, Stratford-upon-Avon, UK
  8. Japanese Society of Hypertension 38th Annual Scientific Meeting 2015, Ehime, Japan
  9. Epigenetics, Obesity and Metabolism 2015, Hinxton, Cambridge, UK
  10. 13th International Congress on Obesity, Vancouver, Canada
  • Track 2-1Obesity-associated arterial hypertension
  • Track 2-2Incidence of hypertension and obesity
  • Track 2-3Pathophysiology of obesity-related hypertension
  • Track 2-4Interaction of obesity with consequences of hypertension
  • Track 2-5Prevention & management of weight gain and hypertension
  • Track 2-6Therapies to treat obesity-related hypertension

Renal hypertension, conjointly referred to as renovascular high blood pressure, is elevated pressure caused by nephrosis. It's a syndrome that consists of high pressure caused by the kidneys' secretion response to narrowing of the arteries activity the kidneys (renal artery stenosis). Once functioning properly this secretion axis regulates pressure. Due to low native blood flow, the kidneys erroneously increase pressure of the complete vascular system. It's a kind of secondary high blood pressure, a kind of hypertension whose cause is classifiable. This session in the main accounts for the assorted causes and symptoms of renovascular high blood pressure, along side of its pathological process, diagnosis and treatment.
High pressure is dangerous partially as a result of the patients usually don't expertise the symptoms, thus organ injury will occur slowly while not being recognized. Renal high blood pressure will cause chronic nephrosis. Varied techniques are developed to diagnose excretory organ high blood pressure victimization digital image process of radiographs. Medications are used initial to manage high pressure in excretory organ high blood pressure. In some individuals with renal high blood pressure due to narrowing of the arteries, even taking 3 or a lot of medications each day might not adequately manage pressure. In these situations, a procedure like angioplasty or stenting, to improve blood flow to the kidneys can often help.
Its prevalence is 2% in those who have a pulse pressure of quite a 100 mmHg and roughly 30% in patients who have pulse pressure quite 130mmHg. Patients with renal high blood pressure are at redoubled risk of organ pathology, as well as permanent excretory organ injury, if inadequate medical specialty therapies are used to manage pressure.

Related Conferences:

  1. 4th Nephrology & Therapeutics Conference, September 14-16, 2015 Baltimore, USA
  2. 6th Nephrology & Therapeutics Conference, September 29-October 01, 2016 Miami, USA
  3. 5th Radiology Conference, September 19-20, 2016 Las Vegas, USA
  4. Medical Imaging Conference, May 09-10, 2016 Chicago, USA
  5. 4th Radilogists Conference, March 17-18, 2016 London, UK
  6. Austrian Society of Nephrology and Austrian Society for Hypertension Joint Meeting 2015, Alp Bach, Austria
  7. 2015 Comprehensive Update in Hypertension, New York, USA 
  8. Hypertension Research Conference, California, San Diego
  9. Mexican College of Nephrology 49th Congress 2015, Mazatlan, Mexico
  10. 4th International Conference on Nephrology & Therapeutics, Linthicum Heights, Maryland, USA
  • Track 3-1Indications and symptoms of renal hypertension
  • Track 3-2Pathogenesis of renal hypertension
  • Track 3-3Diagnosis & treatment
  • Track 3-4Risk factors for renal hypertension
  • Track 3-5Renal-artery angioplasty and stenting

Pulmonary hypertension (PH) is a rise of blood pressure within the artery, vein, or respiratory organ capillaries, resulting in shortness of breath, dizziness, fainting, leg swelling and different symptoms. Having pulmonary arterial hypertension (PAH) means one incorporates a high blood pressure within the arteries that go from the lungs to heart. Symptoms of pulmonary cardiovascular disease don't sometimes occur till the condition has progressed. The primary symptom of pulmonary hypertension is sometimes shortness of breath with everyday activities, like climb stairs. Fatigue, dizziness, and fainting spells can also be symptoms. The molecular mechanism of pulmonary arterial hypertension (PAH) isn't acknowledged, however it's believed that the epithelium pathology leads to a decrease within the synthesis of endothelium-derived vasodilators like gas and prostacyclin. Identification of the severe cardiopathy includes principally diagnostic technique or as per the signs and symptoms of the condition. The various connected problems with pulmonary hypertension embody HIV Associated pulmonary cardiovascular disease, liver disease and pH in Association with red blood cell illness.

Idiopathic pulmonary hypertension may be a rare disease with AN incidence of regarding 2-3 cases per million p.a. and a prevalence of regarding fifteen per million. Adult females square measure nearly 3 times additional seemingly to be gift with IPAH than adult males. The presentation of IPAH among kids is additional equally split on gender lines. Up to 4% of individuals that suffer with embolism maintain to develop chronic thromboembolic illness as well as pulmonary hypertension. Levels of mortality square measure terribly high in pregnant ladies with severe pulmonary hypertension.

Related Conferences:

  1. 4th Lung & Respiratory Care Conference, August 01-03, 2016 Manchester, UK
  2. 5th Pulmonologists Meeting, November 17-18, 2016 Dubai, UAE
  3. 2nd Respiratory Medicine Conference, May 09-10, 2016 Chicago, USA
  4. 7th Cardiothoracic Conference, March 29-30, 2016 Atlanta, USA
  5. Interventional Cardiology Conference, Sept 12-14, 2016 Berlin,Germany
  6. Pulmonary Hypertension: Next Generation 2015, London, UK
  7. PHA’s International Pulmonary Hypertension Conference 2016, Dallas, USA
  8. Pulmonary Hypertension Summit 2016, Cleveland, Ohio, USA 
  9. 2016 International Pulmonary Hypertension Conference, Dallas, USA
  10. 8th Annual Meeting of the Saudi Association for Pulmonary Hypertension (SAPH) 2015, Abu Dhabi, UAE
  • Track 4-1Classification of pulmonary hypertension
  • Track 4-2Signs, symptoms and causes of PH
  • Track 4-3Genetics and molecular pathology
  • Track 4-4Diagnosis by echocardiography
  • Track 4-5Treatment and therapies

Gestational hypertension or pregnancy-induced hypertension (PIH) is that the development of recent cardiovascular disease in a very pregnant lady when twenty weeks gestation while not the presence of super molecule within the excretory product or different signs of Pre-eclampsia. It's a brief identification for hypertensive pregnant ladies who don't meet criteria for pre-eclampsia or chronic cardiovascular disease (hypertension initial detected before the 20th week of pregnancy). The identification is modified to, pre-eclampsia, if symptom or new signs of end-organ pathology develop and chronic (primary or secondary) cardiovascular disease, if blood pressure elevation persists ≥12 weeks postnatal.

The risk factors for Gestational hypertension comprise maternal causes like obesity, past history or adolescent maternity, multiple gestations, and case history. There's no specific treatment, however it's monitored closely to quickly establish pre-eclampsia and its grave complications. Drug treatment choices are restricted, as several medications might negatively have an effect on the craniate. Throughout Gestational hypertension ladies should be offered AN integrated package of care, covering admission to hospital, treatment, activity of blood pressure, testing for symptom and blood tests.

Gestational cardiovascular disease in a very future maternity ranges from 1 in 8 (13%) pregnancies to 1 in 2 (53%) pregnancies.

Related Conferences:

  1. Pregnancy Conference, August 29-31, 2016 Sao Paulo, Brazil
  2. 2nd Gynecology & Obstetrics Conference, November 16-18, 2015 San Antonio, USA
  3. PCOS Conference, November 16-18, 2015 Seattle, USA
  4. 3rd Gynecology & Obstetrics Conference, October 17-19, 2016 Dubai, UAE
  5. 2nd PCOS Conference, October 06-08,2016 Miami,USA
  6. International Society for the Study of Hypertension in Pregnancy European Congress 2015, Budapest, Hungary
  7. The 2015 Pregnancy Summit, London, UK
  8. 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy
  9. 2015 NASSHP Conference Preeclampsia and Hypertension in Pregnancy, Chicago, Illinois
  10. International Federation of Placenta Associations (IFPA) 2016 Meeting, Portland, USA
  • Track 5-1Classification of pregnancy induced hypertension
  • Track 5-2Risk factors for gestational hypertension
  • Track 5-3Pre-eclampsia and eclampsia
  • Track 5-4Pathogenesis of pre-eclampsia
  • Track 5-5Management of hypertension in pregnancy
  • Track 5-6Drug treatment of gestational hypertension
  • Track 5-7Long term cardiovascular sequelae of gestational hypertension

Hypertension is the most prevalent and powerful modifiable risk factor for stroke, irrespective of geographic region and ethnic group. Persons with hypertension are about 3 or 4 times more likely to have a stroke. Whereas diastolic BP was once thought to be the most important predictor of stroke, the relationship between stroke and hypertension may be stronger for systolic than for diastolic BP. The association between BP and stroke risk seems to occur on a continuum rather than as a threshold effect. Major strokes have been reported among persons with only “borderline” or “mild” hypertension, and both persons classified as “hypertensive” as well as “normotensive” could have the benefit of BP lowering. Therefore, although the highest BP levels predict the highest relative risk of stroke, the conceptual pendulum has swung in the direction of the continuum of absolute BP levels and somewhat away from the construct of “hypertension” per se. Furthermore, as discussed below, recent evidence points to the fact that mediators of hypertension, such as Ang II, may influence stroke risk independently of Blood pressure elevation.

Hypertension (high blood pressure) remains the single most important modifiable risk factor for stroke, and the impact of hypertension and nine other risk factors together account for 90% of all strokes. Stroke is a leading cause of death and disability, particularly in low-income and middle-income countries. The two major types of stroke include ischaemic stroke (caused by blood clots), which accounts for 85% of strokes, and haemorrhagic stroke (bleeding in the brain), which accounts for 15% of strokes. Prevention of stroke is a major public health priority, but needs to be based on a clear understanding of the key preventable causes of stroke.

  • Track 6-1Idiopathic intracranial hypertension
  • Track 6-2Hypertensive encephalopathy
  • Track 6-3Cerebrovascular dysfunction
  • Track 6-4Transient ischemic attack
  • Track 6-5Brain RAS on blood pressure control

High blood pressure has several causative factors like age, race, case history and obesity, not being physically active, overwhelming tobacco, an excessive amount of salt (sodium) in diet, deficient potassium and Vitamin-D in diet, drinking an excessive amount of alcohol, stress and bound chronic conditions. There are general risk factors which will be accountable for raising anyone's risk of high blood pressure. Though high pressure is commonest in adults, youngsters are also in danger, too. For a few youngsters, high pressure is caused by issues with the kidneys or heart except for a growing variety of youngsters, poor fashion habits, like AN unhealthy diet, fleshiness and lack of exercise, contribute to high pressure. Generally physiological condition contributes to high pressure, as well. Certain diseases and medications are specific causes of high pressure.

Cardiovascular disease represents the leading reason for morbidity and mortality in Western countries, and hypertension-related vessel events have an effect on regarding 37 million individuals annually, worldwide. During this perspective, hypertensive patients are at hyperbolic risk to expertise vessel events throughout life-long period, and treatment of high pressure represents one among the foremost effective ways to cut back cardiovascular risk

Related Conferences:

  1. 8th Cardiologists Conference, November 14-16, 2016 San Francisco
  2. Ischemic Heart Diseases Conference, May 12-13, 2016 Chicago, USA
  3. Cardiovascular Imaging Conference, Nov 10-12, 2016 Istanbul, Turkey
  4. Euro Cardiology Conference, Oct 24-26, 2016 Valencia, Spain
  5. 5th Radiology & Imaging Conference, September 19-20, 2016 Las Vegas, USA
  6. ICCAD 2015 — 11th International Congress on Coronary Artery Disease, Florence, Italy
  7. 2015 Latin American Conference on Cardiometabolic Disease Management, Hautulco, Mexico
  8. British Hypertension Society Annual Scientific Meeting 2015, Stratford-upon-Avon, UK
  9. Japanese Society of Hypertension 38th Annual Scientific Meeting 2015, Ehime, Japan
  10. Coronary CT Angiography, Dallas, USA
  • Track 7-1Controllable risk factors
  • Track 7-2Uncontrollable risk factors
  • Track 7-3Medical risk factors
  • Track 7-4Global cardiovascular risk assessment
  • Track 7-5Multiple risk management

Hypertension, or high blood pressure, is that the leading risk issue related to death within the world however is essentially well and infrequently undiscovered in patients. Hypertension is usually well and solely detected through timeserving screening. Symptoms solely manifest once blood pressure reaches terribly high levels (usually >200 mmHg systolic), and might embrace headaches, giddiness and nosebleeds. It's typically diagnosed once a patient’s blood pressure is repeatedly found to be 140/90 mmHg or higher in an exceedingly clinical setting and average readings taken mistreatment ambulant blood pressure observance or observance reception are on top of 135/85 mmHg. Once hypertension has been diagnosed, any tests ought to be conducted, as well as excrement testing, blood tests, an eye fixed examination and a 12-lead ECG (ECG). Primary hypertension, within which no specific cause is found, affects ninety fifth of patients. Blood pressure is expressed in terms of pulsation blood pressure (higher reading), that reflects the blood pressure once the heart is shrunken (systole), and pulsation blood pressure (lower reading), and that reflects the blood pressure throughout relaxation (diastole). Hypertension may be diagnosed once either systolic pressure, diastolic pressure, or both are raised.

Blood pressure is set by the flow balanced against systemic vascular resistance. The method of maintaining blood pressure is advanced, and involves varied physiological mechanisms, as well as blood vessel baroreceptors, the renin–angiotensin–aldosterone system, chamber symptom amide, endothelins, and corticosteroid and corticosteroid steroids.

Related Conferences:

  1. 6th Clinical Cardiology Conference, November 30-December 02, 2015 San Antonio, USA
  2. Euro Cardiology Conference, Oct 24-26, 2016 Valencia, Spain
  3. 2nd Pediatric Cardiology Conference, September 22-24, 2016 Las Vegas, USA
  4. Interventional Cardiology Conference, Sept 12-14, 2016 Berlin,Germany
  5. 8th Clinical Cardiology Conference, November 14-16, 2016 San Francisco
  6. 2016 International Pulmonary Hypertension Conference, Dallas, USA
  7. Japanese Society of Hypertension 38th Annual Scientific Meeting 2015, Ehime, Japan
  8. ICTHDD 2016: 18th International Conference on Treatment of Hypertension, Dyslipidemia and Diabetes, London, UK
  9. Chinese Society of Cardiology, Shanghai, China
  10. World Summit on Echocardiography, Beijing, China
  • Track 8-1Hypertension differential diagnosis
  • Track 8-2Differential diagnosis I: primary hypertension
  • Track 8-3Differential diagnosis II: secondary hypertension
  • Track 8-4Hyperkinetic borderline hypertension
  • Track 8-5Isolated systolic hypertension
  • Track 8-6Vascular damage in hypertension

Medications to treat high blood pressure includes Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors,  Angiotensin II receptor blockers (ARBs),  Calcium channel blockers and Renin inhibitors. Additional medication sometimes used to treat high blood pressure comprises Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators and Aldosterone antagonists.

No matter what medications a doctor prescribes to treat high blood pressure, lifestyle changes are required to lower blood pressure. Eating a healthier diet with less, exercising regularly, quitting smoking, limiting the amount of alcohol, maintaining a healthy weight or losing weight must be followed up to control high blood pressure.

 

Medications to treat high pressure includes Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers (ARBs), Calcium channel blockers and Renin inhibitors. Extra medication typically used to treat high pressure includes Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators and mineralocorticoid antagonists.

No matter what medications a doctor prescribes to treat high pressure, way changes are needed to lower pressure. Uptake a healthier diet with less, exertion often, quitting smoking, limiting the quantity of alcohol, maintaining a healthy weight or losing weight should be followed up to manage high pressure.

Related Conferences:

  1. Arrhythmia Conference, July 14-15, 2016 Brisbane, Australia
  2. Euro Cardiology Conference, Oct 24-26, 2016 Valencia, Spain
  3. Interventional Cardiology Conference, Sept 12-14, 2016 Berlin,Germany
  4. 7th Cardiothoracic Conference, March 29-30, 2016 Atlanta, USA
  5. 5th Radiology & Imaging Conference, September 19-20, 2016 Las Vegas, USA
  6. 2015 Latin American Conference on Cardiometabolic Disease Management, Hautulco, Mexico
  7. Coronary Artery Disease: Case-Based Learning, Las Vegas, USA
  8. Canadian Cardiovascular Congress, Toronto, Canada
  9. 4th European - Middle East forum on cardiovascular risks, Budapest, Hungary
  10. International Dead Sea Symposium (IDSS) on Innovations in Cardiac Arrhythmias and Device Therapy, Tel Aviv, Israel
  • Track 9-1Medications to treat high blood pressure
  • Track 9-2Lifestyle changes to treat high blood pressure
  • Track 9-3Complementary and alternative treatment for hypertension
  • Track 9-4Follow-up care for high blood pressure

High blood pressure, which is also called hypertension, increases the risk of developing many serious health problems, including heart disease, stroke, and kidney disease. Evaluation and Treatment of High Blood Pressure recommendations have defined “hypertension” as a BP of ≥140/90 mm Hg. The risk of cardiovascular disease in the patient with hypertension can be greatly reduced with effective antihypertensive therapy

Maintenance of normal body weight, following a proper diet plan, lifestyle modification including exercise, avoiding high-sodium content foods, limited alcohol consumption and appropriate medications as prescribed by the doctor may lead to a controlled and manageable blood pressure account. Also monitoring the blood pressure regularly may prevent hypertension and reduce the risk of high blood pressure-related health problems.

Related Conferences:

  1. Healthcare Conference, October 05-07, 2015 New Delhi,India
  2. Cardiovascular Nursing, May 05-07, 2016 Chicago, USA
  3. Primary Healthcare Conference, April 25-27, 2016 Dubai,UAE
  4. Clinical Nursing Conference, Nov 07-09, 2016 Melborne, Australia
  5. 7th Nursing & Healthcare Conference, August 18-20, 2016 Sao Paulo, Brazil
  6. International Society of Hypertension, Seoul, South Korea
  7. ICTHDD 2016: 18th International Conference on Treatment of Hypertension, Dyslipidemia and Diabetes, London, UK
  8. Hypertension Summit 2015, London, UK
  9. British Hypertension Society Annual Scientific Meeting 2015, Stratford-upon-Avon, UK
  10. Cardiovascular Disease Management: A Case-Based Approach, Phoenix, Ariz.

Hypertension is a powerful risk factor for fatal and nonfatal cardiovascular disease events. Data from observational studies indicate that this risk is continuous, without evidence of a threshold, down to blood pressures as low as 115/75 mm Hg. Randomized controlled trials have convincingly shown that treatment of hypertension reduces the risk of stroke, coronary heart disease, congestive heart failure, and mortality.

Various studies of hypertension control have been performed in a variety of epidemiological and practice settings.Despite the recognition that diabetic persons are at especially high risk of cardiovascular disease, studies suggest that hypertension is as poorly controlled in diabetic persons as it is in non-diabetics. Chronic kidney disease represents another comorbidity associated with both difficult blood pressure control and high cardiovascular risk. Various patient characteristics have been associated with uncontrolled hypertension, including age, obesity, and lack of exercise. These characteristics are risk factors for hypertension itself and presumably contribute directly to difficult blood pressure control.

Related Conferences:

  1. Case Reports Conference, March 31-April 02, 2016 Valencia, Spain
  2. 3rd Medical Case Reports Conference, May 09-11, 2016 New Orleans, Louisiana, USA
  3. 2nd Clinical Case Reports Conference, April 18-20, 2016 Dubai, UAE
  4. Digital Pathology Conference, October 31-November 02, 2016 Valencia, Spain 
  5. 5th Pathology Conference, May 09-11, 2016 Chicago, USA
  6. 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy
  7. 2015 Asia Pacific Conference on Cardiometabolic Diseases Management, Mumbai, India
  8. 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension 2015, Istanbul, Turkey
  9. PHA’s International Pulmonary Hypertension Conference 2016, Dallas, USA
  10. 9th International Conference Neonatal & Childhood Pulmonary Vascular Disease 2016, San Francisco, CA

Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension, or high blood pressure, is dangerous because it can lead to strokes, heart attacks, heart failure, or kidney disease. The goal of hypertension treatment is to lower high blood pressure and protect important organs, like the brain, heart, and kidneys from damage. Treatment for hypertension has been associated with reductions in stroke (reduced an average of 35%-40%), heart attack (20%-25%), and heart failure (more than 50%), according to research.                            

Because hypertension rarely causes specific symptoms, it is not identified until an individual’s blood pressure is measured by a physician or it causes a catastrophic complication such as stroke or heart attack.Accurate diagnosis by blood pressure measurement is essential. Many advanced treatment approaches and medications have been established for the treatment and management of hypertension that may describe this session.

Related Conferences:

  1. 4th Personalized Medicine Conference, September 19-21, 2016 Phoenix, USA
  2. 2nd Molecular Medicine & Diagnosis Conference, September 26-28, 2016 Miami, USA
  3. 5th Pathology Conference, May 09-11, 2016 Chicago, USA
  4. 2nd Cytopathology Conference, August 11-12, 2016 Birmingham , UK
  5. 2nd Clinical Case Reports Conference, April 18-20, 2016 Dubai, UAE
  6. Pulmonary Hypertension: Next Generation 2015, London, UK
  7. Hypertension Summit 2015, London, UK
  8. 2015 International conference for innovations in cardiovascular systems, Tel Aviv, Israel
  9. CARDIOTECHNIX 2015 — 3rd International Congress on Cardiovascular Technologies, Lisbon, Portugal
  10. XXII. World Congress of Echocardiography and Cardiology, Istanbul, Turkey

 

High blood pressure, also known as hypertension, affects millions -- even children and teens. It is a common condition that catches up with most people who live into older age. The exact cause of hypertension is unknown, but there are several factors and conditions that may contribute to its occurrence. About one in every four adults has hypertension.

High blood pressure is often called a "silent disease" because people usually don't know they have it; there may be no outward symptoms or a sign, so monitoring the blood pressure is critical. Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension treatment comes in many forms -- from lifestyle changes to medication.

Thus, case study on patients with different forms of Hypertension, may lead to a better way of improvement in emerging ideas or techniques for treating High Blood Pressure. 

Related Conferences:

  1. Case Reports Conference, March 31-April 02, 2016 Valencia, Spain
  2. 3rd Medical Case Reports Conference, May 09-11, 2016 New Orleans, Louisiana, USA
  3. 2nd Clinical Case Reports Conference, April 18-20, 2016 Dubai, UAE
  4. Digital Pathology Conference, October 31-November 02, 2016 Valencia, Spain 
  5. 5th Pathology Conference, May 09-11, 2016 Chicago, USA
  6. Cardiovascular Disease Management: A Case-Based Approach, October 01-02 2015, Ariz
  7. 2015 Asia Pacific Conference on Cardiometabolic Diseases Management, Mumbai, India
  8. International Society of Hypertension, September 24-29 2016, South Korea
  9. 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension 2015, Istanbul, Turkey
  10. PHA’s International Pulmonary Hypertension Conference 2016, Dallas, USA